All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
VivoCAR™ Anti-CD117 (20376) h(CD28-41BB-CD3z) CAR saRNA employs a high-efficiency saRNA backbone to deliver the 20376 clone. For in vivo therapy, this clone is distinguished by its precise binding kinetics to CD117, optimized for targeting leukemic cells with high target density. By utilizing the biological magnification effect of saRNA, the product achieves sustained CAR expression following in situ reprogramming, providing a potent and dose-sparing strategy for depleting malignant clones in the bone marrow before stem cell transplantation.
There are currently no customer reviews or questions for VivoCAR™ Anti-CD117 (20376) h(CD28-41BB-CD3z) CAR saRNA (XS-0326-XU96). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION